Objective. We have reported that the prevalence of atherosclerotic plaques and their
echolucency was increased in systemic lupus erythematosus (SLE). We here study …

Objective Elevated levels of antibodies against oxidized low-density lipoprotein (LDL)
frequently occur in patients with systemic lupus erythematosus (SLE) and these antibodies …

Objective Although antiphospholipid antibodies (aPL) are associated with arterial and
venous thrombosis in systemic lupus erythematosus (SLE), the extent to which they …

Antiphospholipid and anti-oxidized LDL (anti-oxLDL) antibodies are associated with
thrombosis and atherosclerosis. Rheumatoid arthritis (RA) is characterized by excess …

Oxidative stress and LDL modification (oxLDL) are early pro-atherogenic events. OxLDL
binds β2GPI producing immunogenic oxLDL/β2GPI complexes. Antibodies to these …

Cardiovascular manifestations are common in systemic lupus erythematosus (SLE).
Oxidized low-density lipoprotein (oxLDL) is implicated in cardiovascular disease, especially …

Objective To determine whether antiphospholipid antibodies (aPL) occur before the
diagnosis of systemic lupus erythematosus (SLE) and before initial clotting events, and …

Objective. To determine if there is an association between low levels of high‐density
lipoprotein cholesterol (HDL), apolipoprotein A1 (Apo A1), total cholesterol, and …

Background Premature atherosclerosis is observed in systemic lupus erythematosus (SLE).
Oxidative modification of LDL is associated with atherosclerotic plaque formation. Objectives …

Fluctuations in the titers of anticardiolipin antibodies (aCL) have been reported in systemic
lupus erythematosus (SLE) patients, but their relation with thrombosis is not completely …